444 related articles for article (PubMed ID: 11426982)
1. Negative predictive value of human papillomavirus test following conization of the cervix uteri.
Jain S; Tseng CJ; Horng SG; Soong YK; Pao CC
Gynecol Oncol; 2001 Jul; 82(1):177-80. PubMed ID: 11426982
[TBL] [Abstract][Full Text] [Related]
2. Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen.
Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang KG; Huang HJ; Chao A
Am J Obstet Gynecol; 2001 Apr; 184(5):940-5. PubMed ID: 11303202
[TBL] [Abstract][Full Text] [Related]
3. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence?
Nagai Y; Maehama T; Asato T; Kanazawa K
Gynecol Oncol; 2000 Nov; 79(2):294-9. PubMed ID: 11063660
[TBL] [Abstract][Full Text] [Related]
4. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
[TBL] [Abstract][Full Text] [Related]
5. Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis.
Bodner K; Bodner-Adler B; Wierrani F; Kimberger O; Denk C; Grünberger W
Anticancer Res; 2002; 22(6B):3733-6. PubMed ID: 12552985
[TBL] [Abstract][Full Text] [Related]
6. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.
Costa S; De Simone P; Venturoli S; Cricca M; Zerbini ML; Musiani M; Terzano P; Santini D; Cristiani P; Syrjänen S; Syrjänen K
Gynecol Oncol; 2003 Aug; 90(2):358-65. PubMed ID: 12893200
[TBL] [Abstract][Full Text] [Related]
8. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
[TBL] [Abstract][Full Text] [Related]
9. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
[TBL] [Abstract][Full Text] [Related]
10. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions.
Houfflin Debarge V; Collinet P; Vinatier D; Ego A; Dewilde A; Boman F; Leroy JL
Gynecol Oncol; 2003 Sep; 90(3):587-92. PubMed ID: 13678729
[TBL] [Abstract][Full Text] [Related]
11. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.
Bar-Am A; Gamzu R; Levin I; Fainaru O; Niv J; Almog B
Gynecol Oncol; 2003 Oct; 91(1):149-53. PubMed ID: 14529675
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of high-risk HPV persistence after laser CO2 conization for high-grade CIN: a prospective clinical study.
Fallani MG; Penna C; Marchionni M; Bussani C; Pieralli A; Andersson KL; Fambrini M
Eur J Gynaecol Oncol; 2008; 29(4):378-82. PubMed ID: 18714574
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus test after conization in predicting residual disease in subsequent hysterectomy specimens.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Obstet Gynecol; 2009 Jul; 114(1):87-92. PubMed ID: 19546763
[TBL] [Abstract][Full Text] [Related]
14. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
Costa S; Sideri M; Syrjänen K; Terzano P; De Nuzzo M; De Simone P; Cristiani P; Finarelli AC; Bovicelli A; Zamparelli A; Bovicelli L
Acta Cytol; 2000; 44(3):310-8. PubMed ID: 10833984
[TBL] [Abstract][Full Text] [Related]
15. Residual disease and presence of human papillomavirus after conization.
Kanamori Y; Kigawa J; Minagawa Y; Irie T; Oishi T; Itamochi H; Cheng X; Terakawa N
Oncology; 1998; 55(6):517-20. PubMed ID: 9778616
[TBL] [Abstract][Full Text] [Related]
16. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer.
Park JY; Lee SM; Yoo CW; Kang S; Park SY; Seo SS
Gynecol Oncol; 2007 Oct; 107(1):39-44. PubMed ID: 17582476
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ).
Sarian LO; Derchain SF; Pitta Dda R; Morais SS; Rabelo-Santos SH
J Clin Virol; 2004 Dec; 31(4):270-4. PubMed ID: 15494268
[TBL] [Abstract][Full Text] [Related]
18. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
19. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y
Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
[TBL] [Abstract][Full Text] [Related]
20. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia.
Fambrini M; Penna C; Pieralli A; Bussani C; Fallani MG; Andersson KL; Scarselli G; Marchionni M
Gynecol Oncol; 2008 Apr; 109(1):59-64. PubMed ID: 18255129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
